Laverock Therapeutics is a gene-silencing company developing programmable advanced therapies by reprogramming cells' natural gene control systems. Its innovative technology repurposes naturally occurring microRNAs (miRNAs) to conditionally silence genes in a programmable, tunable, stable and specific manner, enabling the development of safer, targeted cell therapies. Laverock focuses on applications in regenerative medicine and oncology
- Investment status Current
- Invested 2023
- Category Health & Life Sciences